Multiple biological functions and pharmacological effects of lycorine

Science China Chemistry

Volumn 56, Issue 10, 2013, Pages 1382-1391

  Cao, Zhifei ^a   Yang, Ping ^a   Zhou, Quansheng ^a  

^a National Clinical Research Center for Hematological Diseases   (China)

Author keywords

angiogenesis; anti cancer; anti virus; lycorine; neovascularization; traditional Chinese medicinal herbs

Indexed keywords

ANGIOGENESIS; ANTI VIRUS; ANTI-CANCER; LYCORINE; NEO-VASCULARIZATION; TRADITIONAL CHINESE MEDICINAL HERBS;

BIOCHEMISTRY; DISEASE CONTROL; DISEASES; PLANTS (BOTANY); STRUCTURE (COMPOSITION); TOXICITY; VIRUSES;

BIOLOGICAL SYSTEMS;

EID: 84885622911     PISSN: 16747291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-013-4967-9     Document Type: Article

References (86)

1. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ, Chen Z. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A, 2008, 105(12): 4826-4831
2. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de The H, Chen SJ, Chen Z. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science, 2010, 328(5975): 240-243
3. Chen J, Wang A, Huo HH, Huang PQ. Progress on the total synthesis of natural products in China: From 2006 to 2010. Sci China Chem, 2012, 55(7): 1175-1212
4. Lamoral-Theys D, Decaestecker C, Mathieu V, Dubois J, Kornienko A, Kiss R, Evidente A, Pottier L. Lycorine and its derivatives for anticancer drug design. Mini Rev Med Chem, 2010, 10(1): 41-50
5. Elgorashi EE, Drewes SE, Van Staden J. Organ-to-organ and seasonal variation in alkaloids from Crinum macowanii. Fitoterapia, 2002, 73(6): 490-495
6. Cedron JC, Gutierrez D, Flores N, Ravelo AG, Estevez-Braun A. Synthesis and antiplasmodial activity of lycorine derivatives. Bioorg Med Chem, 2010, 18(13): 4694-4701
7. Van Goietsenoven G, Andolfi A, Lallemand B, Cimmino A, Lamoral-Theys D, Gras T, Abou-Donia A, Dubois J, Lefranc F, Mathieu V, Kornienko A, Kiss R, Evidente A. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells. J Nat Prod, 2010, 73(7): 1223-1227
8. Liu XS, Jiang J, Jiao XY, Wu YE, Lin JH, Cai YM. Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells. Cancer Lett, 2009, 274(1): 16-24
9. Lamoral-Theys D, Andolfi A, Van Goietsenoven G, Cimmino A, Le CB, Wauthoz N, Megalizzi V, Gras T, Bruyere C, Dubois J, Mathieu V, Kornienko A, Kiss R, Evidente A. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight. J Med Chem, 2009, 52(20): 6244-6256
10. McNulty J, Nair JJ, Bastida J, Pandey S, Griffin C. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells. Phytochemistry, 2009, 70(7): 913-919
11. Liu R, Cao Z, Tu J, Pan Y, Shang B, Zhang G, Bao M, Zhang S, Yang P, Zhou Q. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry. Pigment Cell Melanoma Res, 2012, 25(5): 630-638
12. Cao Z, Yu D, Fu S, Zhang G, Pan Y, Bao M, Tu J, Shang B, Guo P, Yang P, Zhou Q. Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicol Lett, 2013, 218(2): 174-185
13. Szlavik L, Gyuris A, Minarovits J, Forgo P, Molnar J, Hohmann J. Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids. Planta Med, 2004, 70(9): 871-873
14. Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res, 2005, 67(1): 18-23
15. Hwang YC, Chu JJ, Yang PL, Chen W, Yates MV. Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay. Antiviral Res, 2008, 77(3): 232-236
16. Zou G, Puig-Basagoiti F, Zhang B, Qing M, Chen L, Pankiewicz KW, Felczak K, Yuan Z, Shi PY. A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology, 2009, 384(1): 242-252
17. Liu J, Yang Y, Xu Y, Ma C, Qin C, Zhang L. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol J, 2011, 8: 483
18. He J, Qi WB, Wang L, Tian J, Jiao PR, Liu GQ, Ye WC, Liao M. Amaryllidaceae alkaloids inhibit nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1. Influenza Other Respi Viruses, 2012, doi: 10.1111/irv.12035.
19. Massardo DR, Manna F, Schafer B, Wolf K, Del GL. Complete absence of mitochondrial DNA in the petite-negative yeast Schizosaccharomyces pombe leads to resistance towards the alkaloid lycorine. Curr Genet, 1994, 25(1): 80-83
20. Del GA, Massardo DR, Manna F, Koltovaya N, Hartings H, Del GL, Wolf K. Correlation of resistance to the alkaloid lycorine with the degree of suppressiveness in petite mutants of Saccharomyces cerevisiae. Curr Microbiol, 1997, 34(6): 382-384
21. Del GL, Massardo DR, Pontieri P, Wolf K. Interaction between yeast mitochondrial and nuclear genomes: Null alleles of RTG genes affect resistance to the alkaloid lycorine in rho0 petites of Saccharomyces cerevisiae. Gene, 2005, 354: 9-14
22. Ch'en MC, Jin SC, Wang YC. Effect of lycorine on the pituitary-adrenal system. Yao Xue Xue Bao, 1965, 12(12): 767-771
23. Yamazaki Y, Kawano Y. Inhibitory effects of herbal alkaloids on the tumor necrosis factor-alpha and nitric oxide production in lipopolysaccharide- stimulated RAW264 macrophages. Chem Pharm Bull (Tokyo), 2011, 59(3): 388-3891
24. Citoglu GS, Acikara OB, Yilmaz BS, Ozbek H. Evaluation of analgesic, anti-inflammatory and hepatoprotective effects of lycorine from Sternbergia fisheriana (Herbert) Rupr. Fitoterapia, 2012, 83(1): 81-87
25. Kang J, Zhang Y, Cao X, Fan J, Li G, Wang Q, Diao Y, Zhao Z, Luo L, Yin Z. Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge. Int Immunopharmacol, 2012, 12(1): 249-256
26. Elgorashi EE, Stafford GI, Van Staden J. Acetylcholinesterase enzyme inhibitory effects of amaryllidaceae alkaloids. Planta Med, 2004, 70(3): 260-262
27. Nair JJ, van Staden J. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids. Nat Prod Commun, 2012, 7(7): 959-962
28. Nino J, Hincapie GM, Correa YM, Mosquera OM. Alkaloids of Crinum x powellii "Album" (Amaryllidaceae) and their topoisomerase inhibitory activity. Z Naturforsch C, 2007, 62(3-4): 223-226
29. McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC, Bastida J. Cytochrome P450 3A4 inhibitory activity studies within the lycorine series of alkaloids. Nat Prod Commun, 2010, 5(8): 1195-1200
30. Kushida N, Atsumi S, Koyano T, Umezawa K. Induction of flat morphology in K-ras-transformed fibroblasts by lycorine, an alkaloid isolated from the tropical plant Eucharis grandiflora. Drugs Exp Clin Res, 1997, 23(5-6): 151-155
31. Baez A, Vazquez D. Binding of [3H]narciclasine to eukaryotic ribosomes. A study on a structure-activity relationship. Biochim Biophys Acta, 1978, 518(1): 95-103
32. Arrigoni O, Arrigoni-Liso R, Calabrese G. Ascorbic Acid as a factor controlling the development of cyanide-insensitive respiration. Science, 1976, 194(4262): 332-333
33. Imai T, Karita S, Shiratori G, Hattori M, Nunome T, Oba K, Hirai M. L-galactono-gamma-lactone dehydrogenase from sweet potato: Purification and cDNA sequence analysis. Plant Cell Physiol, 1998, 39(12): 1350-1358
34. Mellado M, Contreras RA, Gonzalez A, Dennett G, Moenne A. Copper-induced synthesis of ascorbate, glutathione and phytochelatins in the marine alga Ulva compressa (Chlorophyta). Plant Physiol Biochem, 2012, 51: 102-108
35. Ye N, Zhu G, Liu Y, Zhang A, Li Y, Liu R, Shi L, Jia L, Zhang J. Ascorbic acid and reactive oxygen species are involved in the inhibition of seed germination by abscisic acid in rice seeds. J Exp Bot, 2012, 63(5): 1809-1822
36. Schrader KK, Andolfi A, Cantrell CL, Cimmino A, Duke SO, Osbrink W, Wedge DE, Evidente A. A survey of phytotoxic microbial and plant metabolites as potential natural products for pest management. Chem Biodivers, 2010, 7(9): 2261-2280
37. Giordani RB, Weizenmann M, Rosemberg DB, De Carli GA, Bogo MR, Zuanazzi JA, Tasca T. Trichomonas vaginalis nucleoside triphosphate diphosphohydrolase and ecto-5′-nucleotidase activities are inhibited by lycorine and candimine. Parasitol Int, 2010, 59(2): 226-231
38. Giordani RB, Vieira PB, Weizenmann M, Rosemberg DB, Souza AP, Bonorino C, De Carli GA, Bogo MR, Zuanazzi JA, Tasca T. Lycorine induces cell death in the amitochondriate parasite, Trichomonas vaginalis, via an alternative non-apoptotic death pathway. Phytochemistry, 2011, 72(7): 645-650
39. Abbassy MA, el-Gougary OA, el-Hamady S, Sholo MA. Insecticidal, acaricidal and synergistic effects of soosan, Pancratium maritimum extracts and constituents. J Egypt Soc Parasitol, 1998, 28(1): 197-205
40. Onishi Y, Kawano Y, Yamazaki Y. Lycorine, a candidate for the control of period length in mammalian cells. Cell Physiol Biochem, 2012, 29(3-4): 407-416
41. Ch'en MC, Li CH. Some pharmacological actions of lycorine. Yao Xue Xue Bao, 1965, 12(9): 594-600
42. Wu ZP, Chen Y, Xia B, Wang M, Dong YF, Feng X. Two novel ceramides with a phytosphingolipid and a tertiary amide structure from Zephyranthes candida. Lipids, 2009, 44(1): 63-70
43. Nair JJ, Aremu AO, van Staden J. Isolation of narciprimine from Cyrtanthus contractus (Amaryllidaceae) and evaluation of its acetylcholinesterase inhibitory activity. J Ethnopharmacol, 2011, 137(3): 1102-1106
44. Reyes-Chilpa R, Berkov S, Hernandez-Ortega S, Jankowski CK, Arseneau S, Clotet-Codina I, Este JA, Codina C, Viladomat F, Bastida J. Acetylcholinesterase-inhibiting alkaloids from Zephyranthes concolor. Molecules, 2011, 16(11): 9520-9533
45. Salehi SMH, Azadi B, Amin G, Amini M, Sharifzadeh M. The first phytochemical report of Galanthus transcaucasicus Fomin. Daru, 2010, 18(2): 124-127
46. Katoch D, Kumar S, Kumar N, Singh B. Simultaneous quantification of Amaryllidaceae alkaloids from Zephyranthes grandiflora by UPLC-DAD/ESI-MS/MS. J Pharm Biomed Anal, 2012, 71: 187-192
47. Georgieva L, Berkov S, Kondakova V, Bastida J, Viladomat F, Atanassov A, Codina C. Alkaloid variability in Leucojum aestivum from wild populations. Z Naturforsch C, 2007, 62(9-10): 627-635
48. Mu HM, Wang R, Li XD, Jiang YM, Peng F, Xia B. Alkaloid accumulation in different parts and ages of Lycoris chinensis. Z Naturforsch C, 2010, 65(7-8): 458-462
49. Ptak A, El TA, Dupire F, Boisbrun M, Henry M, Chapleur Y, Mos M, Laurain-Mattar D. LCMS and GCMS for the screening of alkaloids in natural and in vitro extracts of Leucojum aestivum. J Nat Prod, 2009, 72(1): 142-147
50. Kaya GI, Cicek D, Sarikaya B, Onur MA, Somer NU. HPLC - DAD analysis of lycorine in Amaryllidaceae species. Nat Prod Commun, 2010, 5(6): 873-876
51. Yamada K, Yamashita M, Sumiyoshi T, Nishimura K, Tomioka K. Total synthesis of (-)-lycorine and (-)-2-epi-lycorine by asymmetric conjugate addition cascade. Org Lett, 2009, 11(7): 1631-1633
52. Jones MT, Schwartz BD, Willis AC, Banwell MG. Rapid and enantioselective assembly of the lycorine framework using chemoenzymatic techniques. Org Lett, 2009, 11(15): 3506-3509
53. John R, Mohamed SK, Mahmoud AR, Ahmed AA. Crinum, an endless source of bioactive principles: A review. Part I. Crinum alkaloids: Lycorine-type alkaloids. IJPSR, 2012, 3(7): 1883-1890
54. Jimenez A, Santos A, Alonso G, Vazquez D. Inhibitors of protein synthesis in eukarytic cells. Comparative effects of some amaryllidaceae alkaloids. Biochim Biophys Acta, 1976, 425(3): 342-348
55. Liu J, Hu WX, He LF, Ye M, Li Y. Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis. FEBS Lett, 2004, 578(3): 245-250
56. Evidente A, Kireev AS, Jenkins AR, Romero AE, Steelant WF, Van Slambrouck S, Kornienko A. Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: Discovery of novel leads for anticancer drug design. Planta Med, 2009, 75(5): 501-507
57. Li Y, Liu J, Tang LJ, Shi YW, Ren W, Hu WX. Apoptosis induced by lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest. Oncol Rep, 2007, 17(2): 377-384
58. Li L, Dai HJ, Ye M, Wang SL, Xiao XJ, Zheng J, Chen HY, Luo YH, Liu J. Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition. Cancer Cell Int, 2012, 12(1): 49
59. Min BS, Gao JJ, Nakamura N, Kim YH, Hattori M. Cytotoxic alkaloids and a flavan from the bulbs of Crinum asiaticum var. japonicum. Chem Pharm Bull (Tokyo), 2001, 49(9): 1217-1219
60. Liu J, Li Y, Tang LJ, Zhang GP, Hu WX. Treatment of lycorine on SCID mice model with human APL cells. Biomed Pharmacother, 2007, 61(4): 229-234
61. Liu J, Hu JL, Shi BW, He Y, Hu WX. Up-regulation of p21 and TNF-alpha is mediated in lycorine-induced death of HL-60 cells. Cancer Cell Int, 2010, 10: 25
62. Hayden RE, Pratt G, Drayson MT, Bunce CM. Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance. Haematologica, 2010, 95(11): 1889-1896
63. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med, 1972, 136(2): 261-276
64. Meadows KL, Hurwitz HI. Anti-VEGF therapies in the clinic.LID Cold Spring Harb Perspect Med, 2012, 2(10). doi: 10.1101/cshperspect.a006577.
65. Al-Husein B, Abdalla M, Trepte M, Deremer DL, Somanath PR. Antiangiogenic therapy for cancer: An update. Pharmacotherapy, 2012, 32(12):1095-1111
66. Braghiroli MI, Sabbaga J, Hoff PM. Bevacizumab: Overview of the literature. Expert Rev Anticancer Ther, 2012, 12(5): 567-580
67. Sitohy B, Nagy JA, Dvorak HF. Anti-VEGF/VEGFR therapy for cancer: Reassessing the target. Cancer Res, 2012, 72(8): 1909-1914
68. Wu JM, Staton CA. Anti-angiogenic drug discovery: Lessons from the past and thoughts for the future. Expert Opin Drug Discov, 2012, 7(8): 723-743
69. Giuliano S, Pages G. Mechanisms of resistance to anti-angiogenesis therapies. Biochimie, 2013, 95(6): 1110-1119
70. Hida K, Akiyama K, Ohga N, Maishi N, Hida Y. Tumour endothelial cells acquire drug resistance in a tumour microenvironment. J Biol chem, 2013, 153(3): 243-249
71. Chen CT, Hung MC. Beyond anti-VEGF: Dual-targeting antiangiogenic and antiproliferative therapy. Am J Transl Res, 2013, 5(4): 393-403
72. Liu R, Yang K, Meng C, Zhang Z, Xu Y. Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. Cancer Biol Ther, 2012, 13(7): 527-533
73. Albini A, Tosetti F, Li VW, Noonan DM, Li WW. Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol, 2012, 9(9): 498-509
74. Shang B, Cao Z, Zhou Q. Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives. Front Med, 2012, 6(1): 67-78
75. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature, 2011, 473(7347): 298-307
76. Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q. Tumor vasculogenic mimicry is associated with poor prognosis of human cancer patients: A systemic review and meta-analysis. Eur J Cancer, 2013, doi: 10.1016/j.ejca.2013.07.148
77. Bao M, Cao Z, Yu D, Fu S, Zhang G, Yang P, Pan Y, Yang B, Han H, Zhou Q. Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity. Toxicol Lett, 2012, 215(3): 174-180
78. Liu R, Cao Z, Pan Y, Zhang G, Yang P, Guo P, Zhou Q. Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells. Anticancer Drugs, 2013, 24(7): 667-676
79. Vrijsen R, Vanden BDA, Vlietinck AJ, Boeye A. Lycorine: a eukaryotic termination inhibitor. J Biol Chem, 1986, 261(2): 505-507
80. Schrader KK, Avolio F, Andolfi A, Cimmino A, Evidente A. Ungeremine and its hemisynthesized analogues as bactericides against flavobacterium columnare. J Agric Food Chem, 2013, 61(6): 1179-1183
81. Mikami M, Kitahara M, Kitano M, Ariki Y, Mimaki Y, Sashida Y, Yamazaki M, Yui S. Suppressive activity of lycoricidinol (narciclasine) against cytotoxicity of neutrophil-derived calprotectin, and its suppressive effect on rat adjuvant arthritis model. Biol Pharm Bull, 1999, 22(7): 674-678
82. McNulty J, Nair JJ, Little JR, Brennan JD, Bastida J. Structure-activity studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids. Bioorg Med Chem Lett, 2010, 20(17): 5290-5294
83. Cortese I, Renna G, Siro-Brigiani G, Poli G, Cagiano R. Pharmacology of lycorine. 1. Effect on biliary secretion in the rat. Boll Soc Ital Biol Sper, 1983, 59(9): 1261-1264
84. Kretzing S, Abraham G, Seiwert B, Ungemach FR, Krugel U, Regenthal R. Dose-dependent emetic effects of the Amaryllidaceous alkaloid lycorine in beagle dogs. Toxicon, 2011, 57(1): 117-124
85. Kretzing S, Abraham G, Seiwert B, Ungemach FR, Krugel U, Regenthal R. Dose-dependent emetic effects of the Amaryllidaceous alkaloid lycorine in beagle dogs. Toxicon, 2011, 57(1): 117-124
86. Kretzing S, Abraham G, Seiwert B, Ungemach FR, Krugel U, Teichert J, Regenthal R. In vivo assessment of antiemetic drugs and mechanism of lycorine-induced nausea and emesis. Arch Toxicol, 2011, 85(12): 1565-1573